This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck + Co., Inc.. Active years: 1993-2005.
Company Filing History:
Years Active: 1993-2005
Title: Jerzy Karczewski: Innovator in Radioligand and Platelet Adhesion Technologies
Introduction
Jerzy Karczewski is a notable inventor based in Blue Bell, PA (US). He has made significant contributions to the fields of radioligands and methods for blocking platelet adhesion. With a total of 2 patents, his work has implications in both medical and pharmaceutical applications.
Latest Patents
Karczewski's latest patents include a radioligand compound, specifically [S]-radiolabeled (+)-N-[1'-(6-cyano-1,2,3,4-tetrahydro-2(R)-naphthalenyl)-3,4-dihydro-4(R)-hydoxyspiro[2H-1-benzopyran-2,4′-piperidin]-6-yl]methanesulfonamide. This invention is directed towards identifying compounds that bind to the Ichannel, which may have antiarrhythmic activity. Additionally, he has developed a method for blocking platelet adhesion to collagen by contacting platelets with a polypeptide having specific sequences.
Career Highlights
Karczewski has had a distinguished career, working at Merck & Co., Inc., where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in drug development and therapeutic strategies.
Collaborations
Throughout his career, Karczewski has collaborated with esteemed colleagues, including Thomas M. Connolly and John W. Butcher. These partnerships have fostered a rich exchange of ideas and have led to significant advancements in their respective fields.
Conclusion
Jerzy Karczewski's contributions to the fields of radioligands and platelet adhesion methods highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of new therapeutic approaches.